Skip to main content

Table 1 Detailed information on cancer types involved in this study

From: Conditional transcriptional relationships may serve as cancer prognostic markers

Cancer type (abbreviated) Cancer type (full name) Sample size in paired comparison Sample size in survival analysis Percentage of censored samples (%)
BRCA Breast invasive carcinoma 112 980 89.1
COAD Colon adenocarcinoma 26 N/A* N/A*
COADREAD§ Colorectal adenocarcinoma 32 N/A* N/A*
HNSC Head and neck squamous cell carcinoma 43 477 60.6
KICH Kidney chromophobe 25 N/A* N/A*
KIPAN§ Pan-kidney cohort (KICH + KIRC + KIRP) 129 759 74.8
KIRC Kidney renal clear cell carcinoma 72 461 67.9
KIRP Kidney renal papillary cell carcinoma 32 257 85.6
LIHC Liver hepatocellular carcinoma 50 320 70.0
LUAD Lung adenocarcinoma 58 449 65.0
LUSC Lung squamous cell carcinoma 51 444 59.5
PRAD Prostate adenocarcinoma 52 445 97.8
THCA Thyroid carcinoma 59 442 97.3
  1. §COADREAD and KIPAN were not among original TCGA panel of cancer types; they were complex cancer types derived by authors of R package TCGA2STAT
  2. *Three cancer types did not return at least ten significant DCLs in their respective CILP analysis, so they were not screened for prognosis DCLs via survival analysis